文献速递腹部MR

钆塞酸增强MRI预测右门静脉栓塞后扩大右半肝切除术后肝衰竭

Predicting liver failure after extended right hepatectomy following right portal vein embolization with gadoxetic acid-enhanced MRI.
PubMed 文献 · Eur Radiol · 2019-03-21

前瞻性评估36例门静脉栓塞后行肝切除患者,在栓塞前、栓塞后14天和28天及肝切除后10天行钆塞酸增强MRI,测量左、右肝叶相对强化率和体积。左叶栓塞前与栓塞后14天相对强化率变化是预测肝切除术后肝衰竭的最佳参数,AUC为0.854,截断值-0.044,敏感度75.0%,特异度92.6%。

要点

  • 门静脉栓塞后14天左肝叶相对强化率变化可预测肝切除术后肝衰竭,AUC 0.854。
  • 截断值-0.044时,敏感度75.0%,特异度92.6%。
  • 除未来残肝体积外,还需评估未来残肝功能以预测肝衰竭风险。

核心结论

  • 钆塞酸增强MRI作为基于影像的肝功能检查,在门静脉栓塞前后进行可帮助预测肝切除术后肝衰竭,风险最早可在门静脉栓塞后14天预测。

研究设计与样本

  • 前瞻性研究,纳入36例门静脉栓塞后行肝切除术的患者,在治疗过程中预设时间点(门静脉栓塞前、栓塞后14天和28天、肝切除后10天)行钆塞酸增强MRI,测定左、右肝叶相对强化率和体积,按有无肝切除术后肝衰竭征象分为两组,采用Mann-Whitney U检验、ROC和logistic回归分析。

诊断标准与关键数值

  • 左叶门静脉栓塞前与栓塞后14天相对强化率变化预测肝切除术后肝衰竭:AUC 0.854(p < 0.001),截断值-0.044,敏感度75.0%,特异度92.6%。

临床应用与阅片要点

  • 作者结论认为,钆塞酸增强MRI作为基于影像的肝功能检查在门静脉栓塞前后进行可帮助预测肝切除术后肝衰竭,风险最早可在门静脉栓塞后14天预测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Predicting post-hepatectomy liver failure (PHLF) after extended right hepatectomy following portal vein embolization (PVE) from serial gadoxetic acid-enhanced magnetic resonance imaging (MRI).

METHODS: Thirty-six patients who underwent hepatectomy following PVE were evaluated prospectively with gadoxetic acid-enhanced MRI examinations at predefined intervals during the course of their treatment, i.e., before and 14 days and 28 days after PVE as well as 10 days after hepatectomy. Relative enhancement (RE) and volume of the left and right liver lobes were determined. The study population was divided into two groups with respect to signs of PHLF. Differences between the two groups were assessed using the Mann-Whitney U test, and predictive parameters for group membership were investigated using ROC and logistic regression analysis.

RESULTS: RE of the left lobe prior to PVE versus 14 days after PVE was significantly lower in patients with PHLF than in those without PHLF (Mann-Whitney U test p < 0.001) and proved to be the best predictor of PHLF in ROC analysis with an AUC of 0.854 (p < 0.001) and a cutoff value of - 0.044 with 75.0% sensitivity and 92.6% specificity. Consistent with this result, logistic linear regression analysis adjusted for age identified the same parameter to be a significant predictor of PHLF (p = 0.040).

CONCLUSIONS: Gadoxetic acid-enhanced MRI performed as an imaging-based liver function test before and after PVE can help to predict PHLF. The risk of PHLF can be predicted as early as 14 days after PVE.

KEY POINTS: • To predict the likelihood of post-hepatectomy liver failure, it is important to estimate not only future liver remnant volume prior to extended liver resection but also future liver remnant function. • Future liver remnant function can be predicted by performing gadoxetic acid-enhanced MRI as an imaging-based liver function test before and after portal vein embolization. • A reduction of relative enhancement of the liver in gadoxetic acid-enhanced MRI after portal vein embolization of 0.044 predicts post-hepatectomy liver failure with 75.0% sensitivity and 92.6% specificity.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Theilig D, Steffen I, Malinowski M, et al. Predicting liver failure after extended right hepatectomy following right portal vein embolization with gadoxetic acid-enhanced MRI. Eur Radiol. 2019. PMID: 30899977. doi:10.1007/s00330-019-06101-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。